Allstate Corp Novavax Inc Transaction History

Allstate Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $486,994 - $998,013	-6,984 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$134.56 - $217.97 $720,165 - $1.17 Million	5,352 Added 327.94%	6,984 $999,000
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $1,422 - $2,164	-8 Reduced 0.49%	1,632 $338,000
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $198,440 - $422,578	1,640 New	1,640 $348,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

Stay updated on Allstate Corp with notifications on news.